Home Healthcare Pharmaceuticals Peri-implantitis Market

Peri-implantitis Market Size, Share & Trends Analysis Report By Method (Surgical, Non-Surgical), By End-User (Hospital, Clinics) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:

Peri-Implantitis Market Size

The global peri-implantitis market size was valued at USD 1.2 billion in 2025 and is projected to grow from USD 1.30 billion in 2026 to USD 2.42 billion by 2034, registering a CAGR of 8.09% during the forecast period from 2026 to 2034. Europe dominated the peri-implantitis market with a market share of 37.4% in 2025.

Peri-implantitis affects around 13% of implants and 18.5% of patients, with its incidence rising from 0.4 to 43.9% within 3-5 years. A systematic review and meta-analysis reported a cumulative success rate of 69% for non-surgical and surgical procedures combined. On the other hand, a retrospective study reported 3-year, 5-year, and 10-year survival rates of implants treated with peri-implantitis surgery as 94.1%, 85.5%, and 71.6%, respectively.

An inflammatory condition known as peri-implantitis affects the tissue surrounding dental implants that have replaced missing or extracted teeth. When the soft tissue surrounding a dental implant becomes infected and starts to deteriorate, it is said to have peri-implant disease. It may result in discomfort, edema, and trouble biting and chewing. Poor oral hygiene is usually the root cause of peri-implantitis, which can be treated with deep cleaning and antimicrobial therapy.

Insufficient oral hygiene practices can result in the accumulation of bacteria on the surface of dental implants, thereby causing peri-implant mucositis, which is characterized by inflammation of the mucous membrane surrounding the implant. Mechanical debridement (removal of contaminated tissue and bacteria) and antibiotic therapy are used to treat peri-implantitis. These treatments clean the region around the implant before the infection spreads to the jawbone.

Peri-implantitis Market Size

Download a Free Sample To learn more about this report.

Method Insights

The global market is segmented into surgical (bone regeneration, open flap debridement, and implantoplasty) and non-surgical (mechanical debridement, laser debridement, antibiotics, and others).

The surgical segment dominates the global market and is expected to grow significantly over the forecast period. The primary goal of surgical therapy is to gain access to the implant surface to remove the biofilm and calcified plaque deposits (calculus), which allows healing and minimizes the risk of further disease progression. Augmentation procedures also aim to regenerate bone deficiency and achieve osseointegration. Access flap surgery (also known as open flap debridement) is a basic surgical method that focuses on decontaminating the in-plant surface under direct vision while also attempting to preserve the soft tissues around the afflicted implants.

Removing an infected, exposed implant surface is called implantoplasty, sometimes fixture modification. Implantoplasty aims to clean the diseased implant surface and create a smooth surface, reducing plaque adherence. The surgical approach is the gold standard for treating peri-implantitis because it allows for thorough debridement and cleansing of the afflicted implant. Technological improvements, an increase in the number of dental treatments, and an increase in the senior population with tooth loss all contribute to the rise of peri-implantitis.

Peri-implantitis Market Size By Segments

Request Customizationto receive a tailored report.

End-User Insights

The global market is segmented into hospitals and clinics. The hospital category dominated the market and will likely continue this trend during the forecast period. This is due to increased hospital and government spending on healthcare infrastructure development. The dental clinic is developing significantly, owing to an expansion in the number of dental clinics and experts performing dental treatments.

Peri-implantitis Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Insights

Europe is the most significant global peri-implantitis market shareholder and is expected to grow significantly over the forecast period. This is due to an increasing patient population with periodontal problems, technical improvements, and expanding public awareness regarding dental implants and associated diseases. European National Health Services cover dental implants and related therapies for individuals suffering from serious periodontal diseases that impair the supporting structures of teeth. This drives the growth of the peri-implantitis market in the region. An increase in the prevalence of peri-implantitis, an increase in the geriatric population, an increase in the number of dental problems and oral diseases, a well-established healthcare infrastructure, and promising reimbursement policies are also some factors propelling the European peri-implantitis market.

Europe Peri-implantitis Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

North America Peri-Implantitis Market Trends

The North American market is growing because of elements such as high dental hygiene awareness, a huge presence of qualified dentists and technologically advanced equipment, and high demand for cosmetic dentistry. According to the WHO Global Oral Health Status Report (2022), oral diseases impact about 3.5 billion people globally, with three out of every four affected living in middle-income countries. Caries of permanent teeth affect an estimated 2 billion individuals worldwide, with 514 million children suffering from caries of primary teeth.

Additionally, the global prevalence of major oral illnesses is increasing due to increased urbanization and changes in the living environment. This is mostly due to insufficient exposure to fluoride (in oral hygiene products or water supply), the availability and affordability of high-sugar-content foods, and restricted access to community oral health care services. The promotion of alcoholic and tobacco products, as well as sugary foods and drinks, has increased consumer use of goods that worsen oral health conditions and other NCDs.

Asia Pacific Peri-Implantitis Market Trends

The Asia-Pacific market is expected to expand over the forecast period due to the large population, supportive government initiatives, and availability of top-notch healthcare facilities in these nations. Dental practitioners routinely prescribe Dental Implants (DIs) to replace lost natural teeth, which are increasing in popularity in populous countries such as India and China. Similarly, India and China are the largest tobacco-producing and consuming countries, respectively, with the lowest smoking awareness. These are the elements that are predicted to drive the peri-implantitis market in the area.

List of Key and Emerging Players in Peri-implantitis Market

Straumann
Nobel Bio Care
Dentsply Sirona
BioHorizons
MIS Implants Technologies Ltd.
Neoss
Osstem Implant
Biotech Dental
Zimmer Biomet

Key Industry Developments

April 2026
Straumann expanded its dental biomaterials and implant care portfolio by advancing solutions focused on implant maintenance, infection management, and improved long-term implant outcomes. The company continued research and development activities supporting prevention and treatment of peri-implant complications.
February 2026
Dentsply Sirona expanded its dental solutions portfolio by introducing advancements in implant dentistry technologies and clinical support systems. The company continued focusing on improving implant success rates through better diagnostics, treatment planning, and maintenance solutions.
January 2026
Geistlich Pharma strengthened its regenerative dentistry portfolio by advancing biomaterials used in periodontal and peri-implant treatments. The company continued developing regenerative solutions aimed at supporting tissue healing and improving outcomes in dental procedures.
November 2025
Nobel Biocare expanded its implant dentistry initiatives by strengthening clinical education and technology solutions focused on implant rehabilitation and maintenance. The company continued supporting dental professionals with tools for improved implant care.
September 2025
BioHorizons expanded its dental implant product portfolio by advancing implant surface technologies and treatment solutions designed to improve osseointegration and reduce complications associated with implant procedures.
July 2025
Institut Straumann AG increased investments in digital dentistry and implant treatment solutions, supporting improved diagnosis, monitoring, and personalized treatment approaches for implant-related conditions.

Report Scope

Segmentation

By Method 2
  • Surgical
  • Non-Surgical
By End-User 2
  • Hospital
  • Clinics

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 7
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage Straumann · Nobel Bio Care · Dentsply Sirona · BioHorizons · MIS Implants Technologies Ltd.
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The peri-implantitis market size is valued at USD 1.30 Billion in 2026 and is projected to reach USD 2.42 Billion by 2034, at a CAGR of 8.09% during the forecast period 2026-2034.

Europe dominated the market with a share of 37.4% in 2025.

The leading players in this market are Straumann, Nobel Bio Care, Dentsply Sirona, BioHorizons, MIS Implants Technologies Ltd..

The peri-implantitis market is projected to grow at a CAGR of 8.09% during the forecast period of 2026 2034.
About the Author
Debashree Bora
Debashree Bora
Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now

We are featured on: